These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 19332866

  • 1. Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function.
    Azurmendi PJ, Fraga AR, Galan FM, Kotliar C, Arrizurieta EE, Valdez MG, Forcada PJ, Stefan JS, Martin RS.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2458-63. PubMed ID: 19332866
    [Abstract] [Full Text] [Related]

  • 2. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function.
    Borresen ML, Wang D, Strandgaard S.
    Am J Nephrol; 2007 Aug; 27(3):240-6. PubMed ID: 17389784
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
    Zheng D, Wolfe M, Cowley BD, Wallace DP, Yamaguchi T, Grantham JJ.
    J Am Soc Nephrol; 2003 Oct; 14(10):2588-95. PubMed ID: 14514736
    [Abstract] [Full Text] [Related]

  • 4. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
    [Abstract] [Full Text] [Related]

  • 5. Carotid vascular remodelling in patients with autosomal dominant polycystic kidney disease.
    Rong S, Jin X, Ye C, Chen J, Mei C.
    Nephrology (Carlton); 2009 Feb; 14(1):113-7. PubMed ID: 19335845
    [Abstract] [Full Text] [Related]

  • 6. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 7. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM, Meijer E, Boertien WE, Sinkeler SJ, Tent H, de Jong PE, Navis G, Gansevoort RT.
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [Abstract] [Full Text] [Related]

  • 8. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
    Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT.
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
    [Abstract] [Full Text] [Related]

  • 9. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
    Heo NJ, Ahn JM, Lee TW, Chin HJ, Na KY, Chae DW, Kim S.
    Hypertens Res; 2010 Jun; 33(6):573-8. PubMed ID: 20379188
    [Abstract] [Full Text] [Related]

  • 10. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K, Matsumoto S, Aso Y, Inukai T.
    J Diabetes Complications; 2006 Jun; 20(2):98-104. PubMed ID: 16504838
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
    Kelleher CL, McFann KK, Johnson AM, Schrier RW.
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
    [Abstract] [Full Text] [Related]

  • 12. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E, Boertien WE, Nauta FL, Bakker SJ, van Oeveren W, Rook M, van der Jagt EJ, van Goor H, Peters DJ, Navis G, de Jong PE, Gansevoort RT.
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease.
    Turkmen K, Tufan F, Alpay N, Kasıkcioglu E, Oflaz H, Ecder SA, Ecder T.
    Intern Med J; 2012 Feb; 42(2):146-53. PubMed ID: 21118411
    [Abstract] [Full Text] [Related]

  • 14. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J, Obeidová H, Lenícek M, Stekrová J, Merta M, Maixnerová D, Vítek L, Viklický O, Tesar V.
    Kidney Blood Press Res; 2008 Feb; 31(6):398-403. PubMed ID: 19060482
    [Abstract] [Full Text] [Related]

  • 15. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T, Vondrichová H, Strízová J, Sikut M, Janda J, Schärer K.
    Cas Lek Cesk; 1999 Mar 15; 138(6):178-84. PubMed ID: 10510532
    [Abstract] [Full Text] [Related]

  • 16. The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD.
    Higashihara E, Nutahara K, Horie S, Muto S, Hosoya T, Hanaoka K, Tuchiya K, Kamura K, Takaichi K, Ubara Y, Itomura M, Hamazaki T.
    Nephrol Dial Transplant; 2008 Sep 15; 23(9):2847-52. PubMed ID: 18372389
    [Abstract] [Full Text] [Related]

  • 17. Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.
    Karava V, Benzouid C, Hogan J, Dossier C, Denjean AP, Deschênes G.
    Pediatr Nephrol; 2018 Sep 15; 33(9):1513-1521. PubMed ID: 29774463
    [Abstract] [Full Text] [Related]

  • 18. Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease.
    de Almeida EA, de Oliveira EI, Lopes JA, Almeida AG, Lopes MG, Prata MM.
    Rev Port Cardiol; 2007 Mar 15; 26(3):235-43. PubMed ID: 17549981
    [Abstract] [Full Text] [Related]

  • 19. Renal response to prostaglandin E1 infusion in polycystic kidney disease versus non-polycystic renal disease.
    Uemasu J, Munemura C, Fujihara M, Kawasaki H.
    Clin Nephrol; 1995 Oct 15; 44(4):225-30. PubMed ID: 8575121
    [Abstract] [Full Text] [Related]

  • 20. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
    Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD.
    Nephrol Dial Transplant; 2004 Nov 15; 19(11):2761-8. PubMed ID: 15353578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.